Dr. Misra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E. Chicago Avenue
Box 29
Chicago, IL 60611Phone+1 312-227-3540
Education & Training
- Baylor College of MedicineFellowship, Child Neurology, 2011 - 2015
- Baylor College of Medicine (Houston)Residency, Pediatrics, 2010 - 2011
- Vanderbilt University School of MedicineClass of 2010
Certifications & Licensure
- IL State Medical License 2017 - 2026
- TX State Medical License 2014 - 2019
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- 44 citationsSpectrum of K V 2.1 Dysfunction in KCNB1-Associated Neurodevelopmental DisordersSeok Kyu Kang, Carlos G. Vanoye, Sunita N. Misra, Dennis M. Echevarria, Jeffrey D. Calhoun
Annals of Neurology. 2019-12-01 - 1 citationsTaking a Newer, Faster, Intranasal Route: A Narrative Review of Transitioning to a Less-Invasive Rescue Treatment for Seizure Clusters.Jurriaan M Peters, Danielle A Becker, Sunita N Misra, Enrique Carrazana, Adrian L Rabinowicz
Patient Preference and Adherence. 2024-01-01 - 14 citationsSignificant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy f...Sunita N Misra, Michael R Sperling, Vikram R Rao, Jurriaan M Peters, Charles Davis
Epilepsia. 2022-10-01
Press Mentions
- New Quality of Life Data for Valtoco® (Diazepam Nasal Spray) Civ in the Treatment of Seizure Clusters Published in Epilepsy & BehaviorJuly 20th, 2022
- Evaluation of Safety in Exceeding Maximum Adult Doses of Commonly Used Second-Generation Antiepileptic Drugs in Pediatric PatientsOctober 8th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: